Table 3 Risk of death in lung squamous cell carcinoma patients according to FLIP and procaspase-8 expression within the nucleus and cytoplasm in tumor and stromal compartments

From: IHC-based subcellular quantification provides new insights into prognostic relevance of FLIP and procaspase-8 in non-small-cell lung cancer

 

Alive, n=37 (%)

Dead, n=52 (%)

Unadjusted hazard ratios (95% confidence intervals)

Adjusted a hazard ratios (95% confidence intervals)

Tumoral FLIP nucleus

 Low (92)

7 (18.9)

19 (36.5)

1.00

1.00

 High (>92)

30 (81.1)

33 (63.5)

0.70 (0.40–1.23)

0.66 (0.36–1.23)

Tumoral FLIP cytoplasm

 Low (231)

28 (75.7)

28 (53.9)

1.00

1.00

 High (>231)

9 (24.3)

24 (46.2)

1.62 (0.94–2.81)

1.31 (0.70–2.44)

Stromal FLIP nucleus

 Low (86.5)

22 (59.5)

41 (78.9)

1.00

1.00

 High (>86.5)

15 (40.5)

11 (21.2)

0.55 (0.28–1.06)

0.52 (0.25–1.10)

Stromal FLIP cytoplasm

 Low (127.5)

18 (48.7)

17 (32.7)

1.00

1.00

 High (>127.5)

19 (51.4)

35 (67.3)

1.41 (0.79–2.51)

1.08 (0.57–2.05)

Tumoral procaspase-8 nucleus

 Low (59.5)

8 (21.6)

17 (32.7)

1.00

1.00

 High (>59.5)

29 (78.4)

35 (67.3)

0.77 (0.43–1.38)

0.73 (0.37–1.44)

Tumoral procaspase-8 cytoplasm

 Low (147.5)

10 (27.0)

21 (40.4)

1.00

1.00

 High (>147.5)

27 (73.0)

31 (59.6)

0.87 (0.50–1.52)

0.84 (0.45–1.55)

Stromal procaspase-8 nucleus

 Low (36.5)

16 (43.2)

16 (30.8)

1.00

1.00

 High (>36.5)

21 (56.8)

36 (69.2)

1.49 (0.83–2.70)

1.64 (0.87–3.09)

Stromal procaspase-8 cytoplasm

 Low (88.5)

11 (29.7)

19 (36.5)

1.00

1.00

 High (>88.5)

26 (70.3)

33 (63.5)

0.98 (0.56–1.73)

1.16 (0.59–2.28)

  1. a Adjustments included age, sex, smoking status, TNM stage, tumor size, tumor grade and surgery type.